Increased levels of substance P in patients taking beta-blockers are linked with a protective effect on oropharyngeal dysphagia.

Marta MiaronsN TomsenW NascimentoÀ EspínD López-FaixóPere ClavéL Rofes

Published in: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2018)

We have found that serum and saliva SP levels are greater in patients TBB. This increase in SP levels could be the action mechanism by which beta-blockers protect patients from OD.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
patient reported outcomes